Lantern Pharma Inc (LTRN) — Financial Flexibility Index

Latest as of June 2026: -0.25x

Lantern Pharma Inc (LTRN) has a Financial Flexibility Index of -0.25x as of June 2026. Free cash flow of $-2.94 Million (operating CF $-2.94 Million minus capex $0.00) represents 0% of total liabilities ($11.82 Million). Check Lantern Pharma Inc (LTRN) tangible net worth to evaluate the tangible quality of the company's equity base.

Financial Flexibility Index

-0.25x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-2.94 Million
Operating CF − Capex

Total Liabilities

$11.82 Million
USD

Capital Expenditures

$0.00
USD

Lantern Pharma Inc Financial Flexibility Index (2018–2025)

Historical Financial Flexibility Index trend for Lantern Pharma Inc across 8 annual periods. For the full cash flow conversion analysis, see Lantern Pharma Inc operating cash flow efficiency.

Annual Financial Flexibility Index for Lantern Pharma Inc (2018–2025)

Year-by-year free cash flow to debt coverage for Lantern Pharma Inc. Explore Lantern Pharma Inc (LTRN) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2025 -3.48x $-15.68 Million $-15.68 Million $4.50 Million ▲ +14.2%
2024 -4.06x $-17.80 Million $-17.81 Million $4.38 Million ▲ +22.4%
2023 -5.23x $-14.33 Million $-14.35 Million $2.74 Million ▼ -14.9%
2022 -4.55x $-12.74 Million $-12.77 Million $2.80 Million ▼ -2.4%
2021 -4.45x $-10.58 Million $-10.59 Million $2.38 Million ▲ +47.9%
2020 -8.53x $-5.64 Million $-5.65 Million $660.84K ▼ -96.6%
2019 -4.34x $-2.12 Million $-2.13 Million $489.29K ▼ -123.3%
2018 -1.94x $-1.27 Million $-1.27 Million $651.63K
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities